UK Allows Early Access To Alnylam’s Lumasiran For Ultra-Rare Disorder
Executive Summary
UK patients diagnosed with primary hyperoxaluria Type 1 can now be prescribed lumasiran, which is still being reviewed for EU-wide approval. Patients in the US, Germany and other EU countries can also get the drug under early access schemes.